IMAB - I-Mab - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMAB is currently covered by 4 analysts with an average price target of $13.16. This is a potential upside of $10.71 (437.14%) from yesterday's end of day stock price of $2.45.

I-Mab's activity chart (see below) currently has 16 price targets and 31 ratings on display. The stock rating distribution of IMAB is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 34% with an average time for these price targets to be met of 77.4 days.

Highest price target for IMAB is $7, Lowest price target is $4, average price target is $5.33.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 04-Apr-2025. First documented stock forecast 11-Feb-2020.

Best performing analysts who are covering IMAB - I-Mab:

Louise Chen Andrew Fein Joseph Catanzaro Gil Blum Kelly Shi

Currently out of the existing stock ratings of IMAB, 14 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$7

$4.55 (185.71%)

2 months 3 days ago
(04-Apr-2025)

1/5 (20%)

$6.32 (929.41%)

85

Buy

$4

$1.55 (63.27%)

$6

2 months 3 days ago
(04-Apr-2025)

0/5 (0%)

$3.32 (488.24%)

Buy

$5

$2.55 (104.08%)

$16

1 years 3 months 26 days ago
(12-Feb-2024)

1/2 (50%)

$3.2 (177.78%)

78

Buy

1 years 9 months 2 days ago
(05-Sep-2023)

3/4 (75%)

$13.97 (18.37%)

133

Buy

$35

2 years 2 months 4 days ago
(03-Apr-2023)

1/4 (25%)

$26.73 (323.22%)

91

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMAB (I-Mab) average time for price targets to be met?

On average it took 77.4 days on average for the stock forecasts to be realized with a an average price target met ratio 34

Which analyst has the current highest performing score on IMAB (I-Mab) with a proven track record?

LOUISE CHEN

Which analyst has the current lower performing score on IMAB (I-Mab) with a proven track record?

KELLY SHI

Which analyst has the most public recommendations on IMAB (I-Mab)?

Louise Chen works at SCOTIABANK and has 9 price targets and 5 ratings on IMAB

Which analyst is the currently most bullish on IMAB (I-Mab)?

Andrew Fein with highest potential upside - $4.55

Which analyst is the currently most reserved on IMAB (I-Mab)?

Louise Chen with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?